Praxis Precision Medicines Inc

+0.18 (+2.04%)
Earnings Announcements

Praxis Posts Quarterly Net Loss Per Share Attributable $1.51

Published: 05/09/2022 21:23 GMT
Praxis Precision Medicines Inc (PRAX) - Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2022 Financial Results.
Praxis Precision Medicines - Cash and Investments of $222.5 Million As of March 31, 2022 Supports Runway Into 3q23.
Qtrly Net Loss per Share Attributable $1.51.
Q1 Earnings per Share View $-1.31 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.40

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.31

More details on our Analysts Page.